Primary and lasting benefits in pregnancy. http://www.doctoryourself.com/klennerpaper.html Observations made on over 300 consecutive obstetrical cases using supplemental ascorbic acid, by mouth, convinced me that failure to use this agent in … [Continue reading]
Long term effect and safety of Wharton’s jelly-derived mesenchymal stem cells on type 2 diabetes
While updating my database of human clinical trials using expanded human umbilical cord mesenchymal cells I came across a new article (April, 2016) describing a 36-month safety in subjects given intravenous cells for in a type 2 diabetes study. The … [Continue reading]
Treatment with Mesenchymal Stem Cells Shown to be Safe for Dog Muscular Dystrophy
Duchenne Muscular Dystrophy (DMD) is a degenerative genetic disorder that affects the muscles in the body in a progressive manner, leading to eventual death. Mesenchymal stem cells (MSC) are able to reach the affected muscle cells and to start tissue … [Continue reading]
Umbilical Cord Mesenchymal Stem Cells as Preeclampsia Treatment
Treatment with human umbilical cord mesenchymal stem cells is shown to be effective in controlling hypertension and reducing the infiltration of inflammatory cells in the placenta, in this preeclampsia rat model. Reprod Sci. 2016 Feb 17. … [Continue reading]
Umbilical cord MSC treatment improves liver condition in rat acute liver failure
Human umbilical cord mesenchymal stem cells (hUCMSC) were found to improve liver condition in rats after acute liver failure, slowing the degeneration of liver cells. The results were comparable whether treatment was administered intravenously or via … [Continue reading]
Human CD34 improves locomotor function in spinal cord injury rats
In this new 2016 study, rats with spinal cord injury (SCI) were treated with conditioned medium or secretome obtained from human CD34 umbilical cord stem cells. Locomotor function was improved; in particular, neurological deficits, cell death, extent … [Continue reading]